€2,670.90
VHI Women's Mini Marathon Oesophageal Cancer Fund (OCF)
VHI Women's Mini Marathon
€2,670.90
Oesophageal Cancer Fund (OCF)
VHI Women's Mini Marathon
VHI Women's Mini Marathon

My Story

Hi Guys, in an effort to keep up Josie’s amazing fundraising we are taking part in the VHI mini marathon on Sunday, June 3rd 2018. Our aim is to raise as much money and awareness for Oesophageal Cancer Fund (OCF) as possible. As you all know, our friend Josie was raising money while fighting this cancer and we want to continue her goal of raising awareness, especially amongst young people.

The chances of beating oesophageal cancer are greater when caught in the early stages, so please check out the OCF page to get informed on the early signs and symptoms.

http://www.lollipopday.ie/oesophageal-cancer-symptoms.php

We would all really really appreciate ANY donation, no matter how small or big it all makes a huge difference. Hopefully we’ll all make it across the finish line in one piece!

Also if anyone would like to join us on the run (or walking) then PLZ do sign up and let us know :)

Caroline, Hollie, Dee, Laura, Susan, Ciara Ruth, Sally, Jill, Aisling, Michelle, Coral and Emma xx

Team

Team OCF for Vhi Women's Mini Marathon 2018

Blob

Please support Team OCF at this year's Vhi Women's Mini Marathon and help raise the €25,000 required to meet our commitment in 2018 to fund the Irish costs of the Neo-AEGIS International Clinical Trial.

Professor John Reynolds, St. James's Hospital explains about this trial -

"The Oesophageal Cancer Fund (OCF) has worked since its inception to reduce the incidence and deaths from oesophageal cancer through prevention, early diagnosis and improving cure rates. Once a patient is diagnosed with oesophageal cancer, usually presenting through difficulty in swallowing, achieving a cure is notoriously difficult, with a cure rate of approximately 40 per cent. Clinical trials of new drugs and radiation therapy in combination with surgery offer the greatest promise to improve prognosis and cure rates. A major trial, NeoAEGIS, led by Irish investigators, is currently active and will include approximately 250 Irish patients in a trial of over 600 patients from major European specialist centres. The trial offers rich potential to improve cure rates, and to make new discovery from associated scientific research, and has attracted worldwide attention to date, as the outcome of the study is anticipated to transform care and outcomes for oesophageal cancer patients. The OCF is a proud supporter and part sponsor of the trial which is administered through Cancer Trials Ireland "

If you can't take part this year, you can still support by giving whatever you can using the 'Give Now' button on one of the supporter pages below. Please also spread the word by sharing our page with your friends and family and help us reach our goal so we can continue to support our research and really make a difference.

Thank you in advance for your generosity, it means a lot!

Visit Team
Team

Team OCF for Vhi Women's Mini Marathon 2018

Blob

Please support Team OCF at this year's Vhi Women's Mini Marathon and help raise the €25,000 required to meet our commitment in 2018 to fund the Irish costs of the Neo-AEGIS International Clinical Trial.

Professor John Reynolds, St. James's Hospital explains about this trial -

"The Oesophageal Cancer Fund (OCF) has worked since its inception to reduce the incidence and deaths from oesophageal cancer through prevention, early diagnosis and improving cure rates. Once a patient is diagnosed with oesophageal cancer, usually presenting through difficulty in swallowing, achieving a cure is notoriously difficult, with a cure rate of approximately 40 per cent. Clinical trials of new drugs and radiation therapy in combination with surgery offer the greatest promise to improve prognosis and cure rates. A major trial, NeoAEGIS, led by Irish investigators, is currently active and will include approximately 250 Irish patients in a trial of over 600 patients from major European specialist centres. The trial offers rich potential to improve cure rates, and to make new discovery from associated scientific research, and has attracted worldwide attention to date, as the outcome of the study is anticipated to transform care and outcomes for oesophageal cancer patients. The OCF is a proud supporter and part sponsor of the trial which is administered through Cancer Trials Ireland "

If you can't take part this year, you can still support by giving whatever you can using the 'Give Now' button on one of the supporter pages below. Please also spread the word by sharing our page with your friends and family and help us reach our goal so we can continue to support our research and really make a difference.

Thank you in advance for your generosity, it means a lot!

Visit Team

Thank You

Top Supporters
Show more Top Supporters Hide

Donations Summary

Open uri20170419 6 1yxtg67
Charity

Oesophageal Cancer Fund (OCF)